Opioid δ-receptor agonists show promise for treating IBS-like symptoms

Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and reducing stress-induced hypermotility.

VRBPAC unanimously recommends monovalent, XBB lineage for next fall’s Covid-19 vaccine campaign

The FDA’s Vaccines and Related Biological Products Advisory Committee met Thursday to assess whether the Covid-19 vaccine needs to be updated, with the committee voting

June 15, 2023

HEALWELL AI Acquires Pentavere Research Group to Enhance AI Healthcare Solutions

What You Should Know: – HEALWELL AI Inc. (TSX: AIDX), a data science and AI company focused on preventative care, has announced a significant step

November 17, 2023

New First-Line Standard for Lung Cancers With EGFR Exon 20 Insertions

MADRID — Amivantamab (Rybrevant) confirmed its clinical benefit in advanced non-small cell lung cancer (NSCLC) with EGFR exon 20 insertions, and in doing so has

October 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.